Exagen Diagnostics Receives $16,817,541 New Round

  • Feed Type
  • Date
    1/26/2016
  • Company Name
    Exagen Diagnostics
  • Mailing Address
    1261 Liberty Way Vista, CA 92081 USA
  • Company Description
    Exagen Diagnostics Inc. discovers, validates and commercializes small sets of genomic markers, providing prognostic reagents for commercial laboratory testing and for pharmaceutical use in clinical trials.
  • Website
    http://www.exagen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,817,541
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 13 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed